717 5.4 WATSON (Yohimbine 5.4 mg)
Pill with imprint 717 5.4 WATSON is , and has been identified as Yohimbine hydrochloride 5.4 mg. It is supplied by Watson Pharmaceuticals.
Yohimbine is used in the treatment of erectile dysfunction; sexual dysfunction, ssri induced and belongs to the drug class impotence agents. FDA has not classified the drug for risk during pregnancy. Yohimbine 5.4 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for 717 5.4 WATSON
More about yohimbine
- Side Effects
- During Pregnancy
- Drug Images
- Drug Interactions
- Support Group
- 9 Reviews – Add your own review/rating
- Drug class: impotence agents
Other brands: Yohimbe
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.